IDG and Nature Reviews Drug Discovery Target Watch
Researchers supported by the IDG program will work with Nature Reviews Drug Discovery (NRDD) to develop new content on a regular basis highlighting understudied protein targets. Read the articles below to learn more about the IDG program and new proteins of interest.
- KNa1.1 channels as a target for treating early-onset epilepsy
May 13, 2020
- PIP5K1A: a potential target for cancers with KRAS or TP53 mutations
April 24, 2020
- Novel drug targets in 2019
April 9, 2020
- GPR84: An immune response dial?
February 20, 2020
- PKMYT1: A forgotten member of the WEE1 family
November 26, 2019
- ADCK3/COQ8a: The choice target of the UbiB protein kinase-like family
September 16, 2019
- TRIC-B: an under-explored druggable ion channel
July 26, 2019
- RIOK2:Straddling the kinase/ATPase line
June 26, 2019
- CDK16: the pick of the understudied PCTAIRE kinases
May 21, 2019
- Novel drug targets in 2018
March 26, 2019
This page last reviewed on August 4, 2020